Cobalt has been supporting breast cancer services in Gloucestershire since the NHS screening programme began in 1990 and played a key role in funding the Thirlestaine Breast Centre. Each year, the Centre conducts over 31,000 screening mammograms and sees up to 200 symptomatic patients weekly. While the Thirlestaine Breast Centre is a vital hub for breast cancer treatment, it has lacked the resources to focus on research efforts. To address this, Cobalt has committed to funding research posts, enabling the Centre to initiate critical breast cancer trials in collaboration with Gloucestershire Hospitals NHS Foundation Trust.

This commitment to funding, amounting to £75,000 over the next 12 months, will help advance breast cancer research and improve patient care locally. With continued support from donations, we can enhance the quality of care for breast cancer patients in Gloucestershire and contribute to broader health research both nationally and internationally.